Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients
Completed
- Conditions
- First Posted Date
- 2006-09-12
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 100
- Registration Number
- NCT00375180
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer
Terminated
- Conditions
- First Posted Date
- 2006-07-28
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 51
- Registration Number
- NCT00358098
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients
- First Posted Date
- 2006-07-13
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 5
- Registration Number
- NCT00351715
- Locations
- π¨π¦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
π¨π¦Tom Baker Cancer Center, Calgary, Alberta, Canada
Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-07-13
- Last Posted Date
- 2017-09-21
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 58
- Registration Number
- NCT00351962
- Locations
- π¨π¦
Tom Baker Cancer Center, Calgary, Alberta, Canada
Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
Not Applicable
- Conditions
- First Posted Date
- 2006-05-25
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 113
- Registration Number
- NCT00330109
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-05-09
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 40
- Registration Number
- NCT00322985
- Locations
- π¨π¦
Cancer Care Manitoba, Winnipeg, Manitoba, Canada
π¨π¦Queen Elizabeth II, Health Services Centre, Halifax,, Nova Scotia, Canada
π¨π¦Ottawa Hospital General Campus, Ottawa, Ontario, Canada
[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2006-05-09
- Last Posted Date
- 2019-08-26
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 92
- Registration Number
- NCT00323076
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute
Completed
- Conditions
- First Posted Date
- 2006-04-14
- Last Posted Date
- 2016-02-26
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 40
- Registration Number
- NCT00314470
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe
Completed
- Conditions
- First Posted Date
- 2006-04-14
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 40
- Registration Number
- NCT00314535
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe
Completed
- Conditions
- First Posted Date
- 2006-04-14
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 5
- Registration Number
- NCT00314522
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Β© Copyright 2024. All Rights Reserved by MedPath